BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31113)

  • 1. [Non-enzymatic fibrinolytic agents].
    Nilsson IM; Hedner U
    Ann Anesthesiol Fr; 1978; 19(8):697-702. PubMed ID: 31113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiological and pharmacological aspects of fibrinolysis].
    Fearnley GR
    Clin Ter; 1971 May; 57(3):205-25. PubMed ID: 5110942
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma fibrinolytic activity following oral anabolic steroid therapy.
    Walker ID; Davidson JF; Young P; Conkie JA
    Thromb Diath Haemorrh; 1975 Sep; 34(1):236-45. PubMed ID: 1103357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis.
    Bielawiec M; Lukjan H; Myƛliwiec M; Dabrowski S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):971-6. PubMed ID: 94894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The position of long-term stimulation of the endogenous fibrinolytic system: present achievements and clinical perspectives.
    Verstraete M
    Thromb Diath Haemorrh; 1975 Dec; 34(3):613-22. PubMed ID: 174236
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective study of a phenformin-like substance (moroxydine chloride) in patients with deficient vessel wall fibrinolysis.
    Tengborn L; Hedner U; Nilsson IM
    J Med; 1982; 13(5-6):353-64. PubMed ID: 6963328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of phenformin and ethyloestrenol in the prevention of deep venous thrombosis in patients undergoing surgery.
    Atkins P; Brown IK; Downie RJ; Haggart BG; Littler J; Robb PM; Santer GJ; Jones I
    Thromb Haemost; 1978 Feb; 39(1):89-96. PubMed ID: 580509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic effect of biguanides.
    Fearnley GR; Chakrabarti R; Hocking ED; Evans J
    Ann N Y Acad Sci; 1968 Mar; 148(3):840-7. PubMed ID: 5241480
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of fibrinolytic and thrombolytic potential in the rat by treatment with an anabolic steroid, furazabol.
    Kumada T; Abiko Y
    Thromb Haemost; 1976 Nov; 36(2):451-64. PubMed ID: 1036845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenformin and ethyloestrenol in recurrent deep venous thrombosis (DVT).
    Hedner U; Nilsson IM; Isacson S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):372-80. PubMed ID: 63424
    [No Abstract]   [Full Text] [Related]  

  • 11. Anabolic steroids and fibrinolysis.
    Lowe GD
    Wien Med Wochenschr; 1993; 143(14-15):383-5. PubMed ID: 8256452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis.
    Fearnley GR
    Adv Drug Res; 1973; 7():107-63. PubMed ID: 4280240
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
    Nilsson IM; Isacson S
    J Clin Pathol; 1972 Jul; 25(7):638-9. PubMed ID: 5070268
    [No Abstract]   [Full Text] [Related]  

  • 14. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological enhancement of fibrinolytic activity and 125I-fibrinogen survival.
    Hickman JA
    J Clin Pathol; 1970 Dec; 23(9):797-800. PubMed ID: 5504373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels.
    Walker ID; Davidson JF; Young P; Conkie JA
    Thromb Diath Haemorrh; 1975 Sep; 34(1):106-14. PubMed ID: 52896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenformin and ethyloestrenol in recurrent venous thrombosis.
    Nilsson IM; Hedner U; Isacson S
    Acta Med Scand; 1975; 198(1-2):107-13. PubMed ID: 1166815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ; Boon GI; Jansen JW; Bouma BN
    Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
    Isacson S; Nilsson IM
    Scand J Haematol; 1970; 7(5):404-8. PubMed ID: 5486783
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Fibrinolytic activity and deep-vein thrombosis.
    Britton BJ; Wood WG; Butler MJ; Peele M; Irving MH; Hawkey C
    Lancet; 1974 Feb; 1(7851):263. PubMed ID: 4130264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.